Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections.

MILLER, Keith, O'NEILL, Alexander John and CHOPRA, Ian (2004). Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections. Antimicrobial agents and chemotherapy, 48 (1), 23-29.

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1128%2FAAC.48.1.23-29.2004
Link to published version:: 10.1128/AAC.48.1.23-29.2004

Abstract

Mutators may present an enhanced risk for the emergence of antibiotic resistance in bacteria during chemotherapy. Using Escherichia coli mutators as a model, we evaluated their ability to develop resistance to antibiotics routinely used for the treatment of urinary tract infections (UTIs). Under conditions that simulate therapeutic drug concentrations in humans, low-level resistance to trimethoprim, gentamicin, and cefotaxime emerged more frequently in mutators than normal strains. Resistance to trimethoprim in both cell types arose from a single point mutation in folA (Ile94-->Leu) and cefotaxime resistance resulted from loss of outer membrane porin OmpF. The mechanisms of gentamicin resistance could not be defined, but resistance did not result from mutations in ribosomal protein L6 (rplF). Although similar mechanisms of low-level antibiotic resistance probably arise in these strains, mutators are a risk factor because the increased generation of mutants with low-level resistance enhances the opportunity for subsequent emergence of high-level resistance.

Item Type: Article
Research Institute, Centre or Group: Biomolecular Sciences Research Centre
Identification Number: 10.1128/AAC.48.1.23-29.2004
Depositing User: Jamie Young
Date Deposited: 01 Jun 2015 11:18
Last Modified: 01 Jun 2015 11:18
URI: http://shura.shu.ac.uk/id/eprint/9964

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics